Search
for

    Sort by

    Research 571–600 of 1000+

    1. Oral Supplementation with l-Cystine, <i>Serenoa repens</i>, <i>Cucurbita pepo</i>, and <i>Pygeum africanum</i> in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study Skin Appendage Disorders · 2024
    2. A Study on the Effectiveness and Safety of Herbal Extract Combination Compared to 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A Randomized, Double-blind, Controlled Trial ˜The œOpen dermatology journal · 2024
    3. A prospective, randomized double-blind, placebo-controlled study for safety and efficacy of SesZen-BioTM: a proprietary Sesbania grandiflora extract in managing hair and scalp health in healthy adults International journal of clinical trials · 2024
    4. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy of a Nutritional Supplement in Female Androgenic Alopecia Dermatologic Therapy · 2023
    5. 181 Topical Sandalore®, a specific OR2AT4-stimulating odorant, ameliorates telogen effluvium: Randomized, double-blinded, placebo-controlled trial Journal of Investigative Dermatology · 2019
    6. 022 Randomized, double-blind, placebo-controlled, single-centre, phase I safety study of intradermal injections of autologous fibroblasts isolated from the non-bulbar dermal sheath of the hair follicle to treat skin aging Journal of Investigative Dermatology · 2017
    7. Effects of Testosterone+Finasteride On Muscle After Spinal Cord Injury: A Randomized Double-Blind, Placebo-Controlled Pilot Study Archives of Physical Medicine and Rehabilitation · 2023
    8. Testosterone+Finasteride Improves Body Composition After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled Pilot Study Archives of Physical Medicine and Rehabilitation · 2023
    9. Effects of Testosterone+Finasteride on Bone After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled Pilot Study Archives of Physical Medicine and Rehabilitation · 2023
    10. Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study Archives of Dermatological Research · 2022
    11. A randomized, double-blind controlled clinical study to evaluate the efficacy and safety of minoxidil topical 2% nanosuspension with aqueous base in the treatment of androgenetic alopecia areata Journal of reports in pharmaceutical sciences · 2021
    12. A multi-centre, double-blind, randomised, vehicle-controlled study for a quantitative estimation of hair re-growth in male subjects with androgenetic alopecia treated over 6 month with two ethanolic PSK 3841 solutions (2.5% and 5%) 2012
    13. Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study Urology · 1999 · 65 citations
    14. Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind, placebo-controlled trial Therapy · 2006 · 47 citations
    15. Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial The Journal of Clinical Endocrinology & Metabolism · 2017 · 25 citations
    16. Treatment of Eyebrow Hypotrichosis Using Bimatoprost: A Randomized, Double-Blind, Vehicle-Controlled Pilot Study Dermatologic surgery · 2013 · 22 citations
    17. Minoxidil 2% lotion for eyebrow enhancement: A randomized, double-blind, placebo-controlled, spilt-face comparative study The Journal of Dermatology · 2013 · 13 citations
    18. Methodology and Challenges to Recruitment to a Randomized, Double-Blind, Placebo-Controlled Trial of Oral DHEA in Postmenopausal Women Journal of Womens Health · 2008 · 9 citations
    19. Alopecia in a Viable Phospholipase C Delta 1 and Phospholipase C Delta 3 Double Mutant PloS one · 2012 · 8 citations
    20. Safety and Efficacy of Rice Bran Supercritical CO<sub>2</sub> Extract for Hair Growth in Androgenic Alopecia: A 16-Week Double-Blind Randomized Controlled Trial Biological & Pharmaceutical Bulletin · 2015 · 7 citations
    21. Direct access to novel chromeno-pyrimidine-N-oxides via tandem base catalyzed double nucleophilic addition/dehydration reaction Tetrahedron Letters · 2013 · 7 citations
    22. [Protective effects of coenzyme Q10 on the adverse reactions of anthracycline antibiotics: using double blind method--with special reference to hair loss]. PubMed · 1983 · 6 citations
    23. Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial Journal of The European Academy of Dermatology and Venereology · 2021 · 5 citations
    24. The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial Trials · 2019 · 4 citations
    25. Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia Dermatologic Surgery · 2016 · 4 citations
    26. Detection of Bim and Puma in mouse hair follicles using immunofluorescence and TUNEL assay double staining Biotechnic & histochemistry · 2015 · 3 citations
    27. Alefacept for Severe Alopecia Areata: A Randomized, Double-blind, Placebo-Controlled Study Yearbook of Dermatology and Dermatologic Surgery · 2011 · 3 citations
    28. P‐46 A placebo‐controlled, double‐blinded study of recombinant IFNγ in dogs with atopic dermatitis Veterinary Dermatology · 2004 · 3 citations
    29. Silymarin in combination with hair follicle transplantation as a potential treatment for refractory vitiligo: A double‐blind randomized controlled trial Journal of Cosmetic Dermatology · 2024 · 2 citations
    30. Evaluation of Patellar Tendon Structural Changes following Biological Treatments: Secondary Analysis of Double-Blinded Clinical Trial of Bone Marrow Mesenchymal Stromal Cells and Leukocyte-Poor Platelet-Rich Plasma Biomedicines · 2024 · 2 citations